Related Experiment Video
Updated: Mar 14, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Lipoprotein(a) Augments Coronary Risk Estimation in Type 2 Diabetes: A Cross-sectional Study.
Sonali Sharma1, Ramesh Kumar Chandak2, Krishna Kumar Sharma3
1Senior Professor, Department of Biochemistry, RUHS College of Medical Sciences, Jaipur, Rajasthan, India, Orcid: https://orcid.org/0000-0001-5514-1618, Corresponding Author.
Adding lipoprotein(a) [Lp(a)] to risk calculators significantly improves coronary heart disease (CHD) risk prediction in type 2 diabetes (T2D) patients. The European Atherosclerosis Society (EAS) algorithm with Lp(a) offers the most robust estimate, enhancing risk stratification.
Area of Science:
- Cardiology
- Endocrinology
- Biochemistry
Background:
- Type 2 diabetes (T2D) is associated with increased coronary heart disease (CHD) risk.
- Existing risk estimation tools for CHD in T2D patients show variability.
- Lipoprotein(a) [Lp(a)] is an emerging biomarker for cardiovascular risk.
Purpose of the Study:
- To evaluate the augmentation of CHD risk prediction in T2D patients by adding Lp(a) to existing risk algorithms.
- To compare the performance of multiple risk calculators with and without Lp(a).
Main Methods:
- A pilot study included 90 T2D patients.
- Clinical and biochemical data, including Lp(a) levels (ELISA), were collected.
- CHD risk was calculated using Framingham, QRISK-3, SCORE-2D, INTERHEART, and EAS algorithms, with and without Lp(a).
Main Results:
- The European Atherosclerosis Society (EAS) algorithm demonstrated the most robust risk estimate.
- Incorporating Lp(a) into risk algorithms significantly improved risk stratification.
- Adding Lp(a) to the EAS algorithm increased risk reclassification by 4.6-19.3%.
Conclusions:
- Significant variation exists in CHD risk prediction among different algorithms in T2D.
- The EAS algorithm, augmented with Lp(a), provides a more accurate risk assessment.
- Larger prospective studies are needed to confirm these pilot findings.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Diabetes Mellitus: Type 2 and Gestational
Coronary Artery Disease II: Pathophysiology
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

